The expression of TAPA (CD81) correlates with the reactive response of astrocytes in the developing rat CNS

被引:15
|
作者
Peduzzi, JD [1 ]
Grayson, TB
Fischer, FR
Geisert, EE
机构
[1] Univ Alabama, Dept Physiol Opt, Birmingham, AL 35294 USA
[2] Univ Alabama, Sch Med, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Psychol, Birmingham, AL 35294 USA
[4] Univ Tennessee, Dept Anat & Neurobiol, Memphis, TN 38163 USA
关键词
astrocytes; TAPA; GFAP; brain injury; scar formation; development; central nervous system; astrogliosis; tetraspan;
D O I
10.1006/exnr.1999.7234
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
During the development of the brain, astrocytes acquire the ability to become reactive and form a scar. This change in the astrocytes occurs at approximately the same time that there is a decrease in the regenerative capacity of the CNS. Previous work from our laboratory had revealed that TAPA (Target of Anti-Proliferative Antibody, also known as CD81) is associated with reactive gliosis and the glial scar. TAPA is a member of the tetraspan family of proteins that appears to be associated with file regulation of cellular behavior. In order to define the role of TAPA in relation to the developmentally regulated CNS response to injury, we examined the levels of TAPA and GFAP immunoreactivity in rat pups that received a penetrating cerebral cortical injury. All of the animals injured at postnatal day 9 (PND 9), PND 18, or as adults, exhibited reactive gliosis scar formation when they were sacrificed 10 days after the cortical. injury. Of the nine animals injured at PND 2, only three displayed reactive gliosis and scar formation. The remaining six rat pups had either a modest gliotic response or no detectable gliosis. The level of TAPA at the site of injury mimicked the reactive gliosis as defined by GFAP immunoreactivity. In all of the rats with a glial scar, there was a dramatic upregulation of TAPA that is spatially restricted to the reactive astrocytes. These results suggest that the upregulation of TAPA is an integral component of glial scar formation, (C) 1999 Academic Press.
引用
收藏
页码:460 / 468
页数:9
相关论文
共 50 条
  • [1] Up-regulation of CD81 (target of the antiproliferative antibody; TAPA) by reactive microglia and astrocytes after spinal cord injury in the rat
    Dijkstra, S
    Geisert, EE
    Gispen, WH
    Bar, PR
    Joosten, EAJ
    JOURNAL OF COMPARATIVE NEUROLOGY, 2000, 428 (02) : 266 - 277
  • [2] RPE express the target of the antiproliferative antibody (TAPA, CD81).
    Geisert, EE
    Geisert, GR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S605 - S605
  • [3] The role of TAPA (CD81)in microglial activation after spinal cord injury in the rat.
    Dijkstra, S
    Geisert, EE
    Gispen, WH
    Bär, PR
    Joosten, EAJ
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 288 - 288
  • [4] Characterization of CD81/TAPA-1 deficient mice.
    Tsitsikov, EN
    GutierrezRamos, JC
    Geha, RS
    FASEB JOURNAL, 1996, 10 (06): : 287 - 287
  • [5] Elevation of CD81 mRNA expression in the CNS of obese yellow mice
    Gardner, W
    Brazda, A
    Kesterson, B
    DIABETES, 2002, 51 : A420 - A420
  • [6] Retinal pigment epithelium of the rat express CD81, the target of the anti-proliferative antibody (TAPA)
    Geisert, EE
    Abel, HJ
    Fan, LY
    Geisert, GR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 (01) : 274 - 280
  • [7] ROLE OF CD81 (TAPA-1) IN T-LYMPHOCYTE ACTIVATION
    VANDERWOUDE, AC
    PERRY, M
    MENU, E
    TSAI, B
    LEVY, S
    BIERER, BE
    BLOOD, 1994, 84 (10) : A283 - A283
  • [8] Regulation glial cell number by TAPA (the target of the antiproliferative antibody, CD81) in the developing rodent brain and retina.
    Geisert, EE
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 228A - 228A
  • [9] The developmental regulation of CD81 in the rat retina
    Pan, Ye
    Brown, Christina
    Wang, XiangDi
    Geisert, Eldon E.
    MOLECULAR VISION, 2007, 13 (20-24): : 181 - 189
  • [10] The CD81 expression in liver in hepatocellular carcinoma
    Inoue, G
    Horiike, N
    Onji, M
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2001, 7 (01) : 67 - 71